BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 21, 2021
View Archived Issues
Axcella Health initiates phase II EMMPOWER study of AXA-1665
Read More
Phase I/II study evaluates CD19 and BCMA CAR T cells in patients with acute leukemia
Read More
Basket evaluation of atezolizumab with BDB-001 and radiotherapy in multiple solid tumors
Read More
Olix initiates phase II study of OLX-10010 as treatment of hypertrophic scars
Read More
Avidity advances preclinical programs in DMD and myotonic dystrophy type 1
Read More
In vivo model developed for evaluating the cytokine release toxicity of bispecific antibodies
Read More
KIF13B linked to progression of wet age-related macular degeneration
Read More
C4 Therapeutics and Roche patent new PROTACs
Read More
Corbus Pharmaceuticals divulges cannabinoid CB2 receptor agonists
Read More
First patients dosed in phase I study of PBI-100
Read More
Biogen identifies BTK inhibitors
Read More
New DHODH inhibitors synthesized by Janssen
Read More
JD Bioscience presents 5-HT2A receptor antagonists
Read More
Phase Ib data for cagrilintide plus semaglutide in overweight or obese subjects
Read More
Incyte initiates phase II study of INCB-054707 in nonsegmental vitiligo
Read More
BBP-711 enters phase I healthy volunteer study
Read More
Phase I study evaluates gene therapy AAV9/CLN7 in Batten disease
Read More
ChAdOx1 nCoV-19 vaccine shows efficacy against the B.1.1.7 variant of SARS-CoV-2
Read More
AACR 2021: Iron fist could make for less toxic cancer drug
Read More
Medivir reports phase II data on remetinostat in squamous cell carcinoma
Read More
Phase I trial evaluates bispecific antibody TNB-585 in metastatic CRPC
Read More
SPECTRA and PULSAR studies on sotatercept for treating PAH show promise
Read More
Giiant uses seed financing to initiate IND-enabling studies with GT-2108 for ulcerative colitis
Read More